Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1281 N 600 E
Logan, UT 84341Phone+1 801-408-1262
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2016 - 2019
- Carle Foundation HospitalResidency, Internal Medicine, 2007 - 2010
- Manipal College of Medical ScienceClass of 2004
Certifications & Licensure
- UT State Medical License 2019 - 2026
- CO State Medical License 2016 - 2025
- ID State Medical License 2020 - 2025
- MT State Medical License 2019 - 2025
- NV State Medical License 2020 - 2025
- MN State Medical License 2013 - 2017
- IL State Medical License 2007 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- Judge, ACP annual meeting, Fellow/Resident Clinical & Research Poster Presentations American College of Physicians, 2015
- Teaching Excellence Award, Internal Medicine Residency Program Mayo Clinic, Rochester, MN, 2015
- Resident Teacher of the Year University of Illinois, Urbana, 2010
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsImmune and autoimmune-related adverse events associated with immune checkpoint inhibitors in cancer therapy.Gentry Teng King, Prashant Sharma, Sarah Lindsey Davis, Antonio Jimeno
Drugs of Today. 2018-02-01 - 38 citationsAdult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant.Prashant Sharma, Enkhtsetseg Purev, Bradley M. Haverkos, Daniel A. Pollyea, Evan Cherry
Blood Advances. 2020-05-26 - 18 citationsShutting Down Acute Myeloid Leukemia and Myelodysplastic Syndrome with BCL-2 Family Protein Inhibition.Prashant Sharma, Daniel A. Pollyea
Current Hematologic Malignancy Reports. 2018-07-07
Journal Articles
- In the literature: Physician Reviews of Hospital Medicine Relevant Research.A. Hamilton, A. Anumandla, Langerman, P. Sharma, P. Bhateja, V. Janamanchi, The Hospitalist., 12/2012
Abstracts/Posters
- Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re...Prashant Sharma, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Post Transplant Prophylaxis with High Dose Valacyclovir through Day 100 Versus Day of Post Transplant Hospital Discharge Decreases Cytomegalovirus Reactivation in Adul...Prashant Sharma, Jennifer MacDonald, Jeff Kaiser, Jennifer Tobin, Matthew Miller, Maheen Abidi, Esther Benamu, Enkhtsetseg Purev, Bradley M. Haverkos and Jonathan A Gu..., Blood 2018 132:4659, 12/2018
- Chronic Graft Versus Host Disease Burden and Relapse Rates Are Lower with Comparable Overall Survival and Graft Versus Host Disease Free, Relapse Free Survival Followi...Prashant Sharma, Enkhtsetseg Purev, Bradley M. Haverkos, Daniel A Pollyea, Clayton Smith, Manali Kamdar, Daniel W Sherbenou, Tomer M Mark, Peter A Forsberg and Jonatha..., Blood 2018 132:4660, http://www.bloodjournal.org/content/132/Suppl_1/4660.abstract, 12/2018
- Join now to see all
Professional Memberships
- Fellow
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: